169 Results (Page 4 of 7)
Mexico Markets Research Reports
Mexico Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Lung Cancer Therapeutics Market will reach a value of $850 Mn from $447 Mn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Lung Cancer Therapeutics Market in Mexico is dominated by a few domestic pharmaceutical companies such as Silanes, Liomont, and PISA. The Lung Cancer Therapeutics Market in Mexico is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Mexico lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Mexico Acne Drugs Market Analysis
This report presents a strategic analysis of the Mexico Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Acne Drugs Market, offering unmatched value, accuracy and expert insights.
Mexico 3D Imaging Market Analysis
This report presents a strategic analysis of the Mexico 3D Imaging Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico 3D Imaging Market, offering unmatched value, accuracy and expert insights.
Mexico Oncology Drugs Market Analysis
This report presents a strategic analysis of the Mexico Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
Mexico Oncology Clinical Trials Market Analysis
Mexico's oncology clinical trials market is projected to grow from $189.8 Mn in 2022 to $296.8 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022-30. The market will be driven by the country's growing expertise and infrastructure, as well as its commitment to international collaboration. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Laboratorios Silanes.
Mexico Artificial Intelligence (AI) in Healthcare Market Analysis
Mexico's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.1 Bn in 2022 to $2.08 Bn by 2030, registering a CAGR of 45.47% during the forecast period of 2022-2030. The market will be driven by the increase in demand for improved healthcare services and government initiatives in improving healthcare infrastructure. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, PROSPERiA & WelbeCare.
Mexico Diabetes Devices Market Analysis
The Mexico Diabetes Devices Market is expected to witness growth from $341 Mn in 2022 to $606 Mn in 2030 with a CAGR of 7.45% for the forecasted year 2022-2030. The demand for diabetes devices is rising as the Mexican population's discretionary income rises. As the economy improves and the middle class grows, this tendency is anticipated to persist. The market is segmented by type and by the end user. Some key players in this market include Famous Tijuana, Medstent, Medyssey, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Mexico Cardiac Surgery Instruments Market Analysis
The Mexico Cardiac Surgery Instruments Market is expected to witness growth from $31 Mn in 2022 to $53 Mn in 2030 with a CAGR of 6.85% for the forecasted year 2022-2030. Heart failure and coronary artery disease are two rising health concerns in Mexico. The overall incidence of these illnesses is anticipated to rise as the population grows and lifestyles change, fueling demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Mexico Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Liver Disease Therapeutics market will reach a value of $550 Mn from $346 Mn in 2022, growing at a CAGR of 6 % during 2022-2030. Liver Disease Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Liomont, Laboratorios Senosiain, and Silanes Laboratorios. The Liver Disease Therapeutics market in Mexico is segmented into different types of disease and different therapy types. Some of the major factors affecting the Mexico Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Mexico Healthcare Insurance Market Analysis
The Mexico healthcare insurance market is projected to grow from $30.39 Bn in 2022 to $55.63 Bn by 2030, registering a CAGR of 7.85% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing demand for healthcare services, regulatory changes, increasing affordability and technological advancements. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Grupo Nacional Provincial, Grupo Financiero Banorte, AXA, Metlife and Allianz.
Mexico Anti Aging Therapeutics Market Analysis
Mexico anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $31 Mn in 2030 with a CAGR of 16.78% for the year 2022-2030. The rising elderly population and increasing awareness about anti-aging treatments are the major factors responsible for the growth of the market. The Mexico anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Novastem, Liventia, and ENDYMED are some of the key competitors in the market.
Mexico Biomaterials in Healthcare Market Analysis
The Mexico Biomaterials in Healthcare Market is expected to witness growth from $2.34 Bn in 2022 to $6.43 Bn in 2030 with a CAGR of 13.45% for the forecasted year 2022-2030. Research and development spending have increased in Mexico, including in the area of biomaterials. By encouraging the creation of fresh and cutting-edge biomaterials, this is anticipated to fuel growth in the Mexico healthcare biomaterials market. The market is segmented by type and by application. Some key players in this market include: BIOMEDICA MEXICANA S.A DE C.V, Medstent, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Mexico ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Mexico's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $443 Mn in 2022 to $806 Mn in 2030 with a CAGR of 7.75% for the year 2022-2030. Major factors responsible for the expansion of the market are an increase in ADHD prevalence in Mexico and the Mexican government’s initiatives to provide novel therapeutic options for ADHD treatment. The Mexico ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmacia Regina, Farmacia San Martin, and Shire are the key players in the market.
Mexico 3D Printing Medical Devices Market Analysis
Mexico 3D Printing Medical Device Market is expected to witness growth from $45 Mn in 2022 to $152 Mn in 2030 with a CAGR of 16.55% for the forecasted year 2022-2030. In Mexico, the rise in chronic diseases, Mexico's ageing population, the growing use of 3D printing technology, and rising healthcare expenditure are all factors that are driving up the demand for 3D Printing medical devices in Mexico. The market is segmented by application, by technology and by end user. Some key players in this market include: GE Healthcare, Stryker, Medtronic, Philips Healthcare and Boston Scientific.
Mexico Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Liver Cancer Therapeutics market will reach a value of $163.5 Mn from $44 Mn in 2022, growing at a CAGR of 17.9 % during 2022-2030. Liver Cancer Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Laboratorios PiSA, Liomont and Genomma Lab Internacional. The Liver Cancer Therapeutics market in Mexico is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Mexico Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Mexico Neurology Devices Market Analysis
The Mexico Neurology Device Market is expected to witness growth from $189 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Mexico's population is quickly ageing, with an increase in the proportion of people over 60. Age increases a person's vulnerability to brain diseases like Alzheimer's, Parkinson's, and stroke. The demand for neurology devices used in the diagnosis and treatment of these disorders, such as neurostimulation devices and imaging systems, is anticipated to increase as a result of this demographic tendency. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Mexico Neurology Clinical Trials Market Analysis
The Mexico Neurology Clinical Trials market is projected to grow from $78.5 Mn in 2022 to $122.7 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses and increased investments in R&D by pharmaceutical companies. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Laboratorios Silanes.
Mexico Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico infectious disease therapeutics market will reach a value of $2.58 Bn from $1.8 Bn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Silanes Laboratories, BIRMEX and Liomont Laboratories. The Infectious Disease Therapeutics market in Mexico is segmented into different therapeutic areas and different diseases type. The major factors affecting the Mexico infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Mexico.
Mexico Artificial Intelligence (AI) in Diagnostics Market Analysis
Mexico's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $15 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by the rising frequency of chronic illnesses and the availability of cutting-edge information technology. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & PROSPERiA.
Mexico Home Healthcare Market Analysis
The Mexico home healthcare market was valued at $5.44 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by service and product. Some key players in this market are Grupo Home Health, GRUPO PTM, Nurses and Caregivers at Home Cura Mexico and Esperanza Home Healthcare Services many more.
Mexico HIV Therapeutics Market Analysis
The Mexico HIV therapeutics market is expected to reach $xx Mn by 2030, up from $206.4 Mn in 2022, with a CAGR of xx% from 2022 to 2030. Local Players such as PiSA Farmaceutica, Laboratorios Liomont, and Silanes Laboratories dominate the HIV therapeutics market in Mexico. The government policies, funding, and initiatives by international organizations to manage HIV infections in the country propel the market. The HIV therapeutics market in Mexico is divided into four segments: type, product, geography, end user, and distribution channel.
Mexico Palliative Care Market Analysis
The Mexico Palliative care market is projected to grow from $196.2 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be private sector investments, the aging population, government support, and the increasing prevalence of chronic diseases. The market is segmented by service type and by the end user. Some of the major players include Wellness Shepherd, Hospice of New Mexico, Presbyterian, and others.
Mexico Electronic Health Records Market Analysis
The Mexico Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented, by application type, and end user. The Mexican government and private sector have been investing in healthcare infrastructure, including the implementation of EHR systems. This investment is expected to continue, driving growth in the EHR market. The key market players are Softline, Medos, Allscripts, Cerner, and others.
Mexico Bioinformatics Market Analysis
The Mexico Bioinformatics market is projected to grow from $230.25 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be a growing healthcare industry, a strong academic and research base, international collaborations, and government initiatives. The market is segmented by technology and by application. Some of the major players include ATGenomics (MEX), Agilent Technologies, IBM Life Sciences, Qiagen, NEC, and Thermo Fisher Scientific.
Mexico Dental Care Market Analysis
Mexico's dental care market size is at around $538.20 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. This report by Insights10 is segmented by treatment type, age group, and clinical setup, and by demography. The market is captured by giant dental chains like Dental Solutions, Dental Cosmetics, Clear Choice Dental, and OrthoDental which take the dental tourism phenomenon in their stride.